Can You Lose Weight on Methimazole?

Losing weight while taking methimazole is an uphill battle for most people, because the drug works by slowing down the metabolic overdrive that hyperthyroidism creates. Most patients gain weight during treatment, not lose it. Roughly two-thirds of people treated for hyperthyroidism gain at least five percent of their body weight, and that gain tends to concentrate in the first six months. That does not mean weight management is hopeless once you are on methimazole, but it does mean you are working against a shifting metabolic landscape that makes the numbers on the scale move in ways that feel frustrating and counterintuitive.

Why Methimazole Pushes Weight Up Instead of Down

When your thyroid is overactive, your body burns through calories at an abnormally fast rate. At the time of diagnosis, resting energy expenditure in people with Graves’ disease has been measured at roughly 40 percent higher than what would be predicted for their age, sex, and body size.¹ Another study found the ratio was even steeper, with resting energy expenditure at diagnosis averaging about 58 percent above what healthy volunteers burn.² That extra burn is what keeps many hyperthyroid patients thin despite eating large amounts of food.

Methimazole works by blocking the production of excess thyroid hormone. As hormone levels fall back toward normal, that metabolic furnace cools off. Within about three months of starting treatment, resting energy expenditure typically drops to near-normal levels, and by six months it can actually dip slightly below what healthy people burn.² Your body is suddenly spending far fewer calories at rest, but your appetite and eating habits have not caught up with that reality. The mismatch between what you are eating and what your body now needs is the primary driver of weight gain on methimazole.

How Much Weight People Actually Gain

The scale of weight gain surprises many patients. In a large study tracking people treated for hyperthyroidism, 65 percent gained at least five percent of their pre-treatment weight, and 38 percent gained ten percent or more. Men gained an average of about 17.6 pounds, while women gained about 12.1 pounds. The bulk of that gain happened in the first six months, though it continued creeping up through the two-year mark.³ Before treatment, these patients weighed less than a matched comparison group. After treatment, men were 1.7 times and women 1.3 times more likely to become obese than they had been at baseline.³

That pattern of “excess” weight regain, where patients end up heavier than they were before their thyroid went haywire, is well recognized in the literature and has been called a “forgotten tale” of hyperthyroidism treatment.⁴ A meaningful fraction of patients do not simply return to their old weight. They overshoot it.

What Is Happening Inside Your Body During Treatment

The weight you gain on methimazole is not all the same kind of tissue, and the timeline matters. Research tracking body composition during Graves’ disease treatment found that fat mass increases first, peaking between about four and twelve weeks after starting the medication. Lean mass, meaning muscle and other non-fat tissue, increases later, between roughly six months and a year into treatment.¹ BMI climbed sharply during the first eight weeks, plateaued for several months, and then drifted slightly downward around the one-year mark, though it remained higher than before treatment began.

This two-phase pattern explains a common frustration: the early weight gain feels like pure fat, because it largely is. The muscle recovery that follows is a healthier development. Hyperthyroidism breaks down muscle tissue, and patients often lose significant muscle mass before diagnosis. One study found that thigh muscle area increased by about 24 percent during treatment for thyrotoxicosis, alongside increases in overall lean body mass.⁵ So some of the weight the scale shows is your body rebuilding muscle it had lost. That part of the gain is genuinely a sign of recovery, even if it feels discouraging.

Who Gains the Most

Not everyone gains the same amount, and the biggest predictor is how sick you were before treatment started. A study examining risk factors for excessive post-treatment weight gain found two variables that mattered most: how much weight the disease caused you to lose before treatment, and how high your free thyroid hormone levels were at diagnosis. For every kilogram of disease-related weight loss before starting treatment, there was a 23 percent increase in the odds of gaining ten percent or more of your body weight afterward. And for every moderate increase in free T4 levels at diagnosis, the odds of excessive gain rose by about 48 percent.⁶

Both of those markers reflect disease severity. If your hyperthyroidism was severe enough to cause dramatic weight loss and sky-high hormone levels, your body has a longer distance to travel back to normal, and it tends to overshoot. Patients whose hyperthyroidism was milder at diagnosis generally gain less. This is worth knowing because it helps set realistic expectations: if you lost a lot of weight rapidly before your diagnosis, regaining much of it is likely, and aggressive dieting during early treatment is fighting a metabolic tide that is hard to resist safely.

Methimazole Compared to Other Treatments for Hyperthyroidism

Methimazole is not the only treatment for an overactive thyroid, and the alternatives carry their own weight trajectories. Radioactive iodine therapy, which destroys part of the thyroid gland, tends to cause more weight gain than methimazole, partly because it often tips patients into hypothyroidism, which further slows metabolism. In one study comparing the two approaches in patients with toxic multinodular goiter, people on methimazole gained an average of about 1.1 kilograms, while those treated with radioactive iodine gained about 2.7 kilograms. Within the radioactive iodine group, patients who became hypothyroid after treatment gained the most, averaging about 3.4 kilograms.⁷

A broader analysis tracking all treatment types found that average weight gain was about 11.8 pounds for patients treated with medication, compared to about 12.3 pounds for radioactive iodine patients who stayed euthyroid, and about 15.6 pounds for radioactive iodine patients who developed hypothyroidism.³ The differences are not enormous, but they suggest that staying on methimazole and maintaining normal thyroid levels without tipping into hypothyroidism tends to produce slightly less weight gain than more destructive treatments.

The Appetite Problem Nobody Warns You About

Hyperthyroidism cranks up appetite alongside metabolic rate. Many patients are used to eating large portions and frequent meals before treatment begins. When methimazole brings thyroid levels down, the calorie burn drops within weeks, but appetite does not automatically follow. Research looking at ghrelin, one of the key hormones involved in hunger signaling, found that ghrelin levels did not explain the increased appetite seen in hyperthyroidism, suggesting the appetite drive involves other pathways that are not fully understood.⁸

What this means practically is that the hunger you feel during and after treatment is partly habit, partly hormonal, and not entirely in your conscious control. Many patients describe feeling ravenous in the early months of methimazole even as their weight climbs. The mismatch between appetite and actual calorie needs tends to narrow over time as thyroid levels stabilize, but it can take months. Recognizing that this gap exists, rather than blaming yourself for lack of willpower, is the first step in managing it.

When and How Weight Loss Becomes Possible

The research does offer a window of hope. In the study tracking body composition over a full year, body weight rose during the first eight weeks, plateaued through about six months, and then began a gradual decline between six and twelve months, even though patients were eating less than they had been at the start.¹ That late-stage dip suggests the body eventually recalibrates to its new metabolic rate. The plateau is not permanent.

This timeline has practical implications. Trying to aggressively diet during the first few months of methimazole is fighting your body at a time when it is actively trying to rebuild lost tissue and readjust its thermostat. Most endocrinologists advise against severe calorie restriction in this window because it can interfere with recovery and muscle rebuilding. The smarter move is to focus on portion awareness and food quality early on, then shift toward more deliberate weight management once thyroid levels have been stable for several months.

Exercise during treatment is both helpful and nuanced. A study of resistance training in medically treated hyperthyroid patients found that it accelerated the recovery of skeletal muscle function and promoted weight gain based on muscle mass improvement.⁹ That might sound contradictory if your goal is weight loss, but rebuilding muscle increases your resting metabolic rate over time, which makes fat loss easier later. Strength training during methimazole treatment is playing a longer game: you may not see the scale drop immediately, but you are building the metabolic foundation that makes sustainable weight management possible once everything stabilizes.

Side Effects That Can Get in the Way

Some patients on methimazole experience side effects that make exercise and active weight management harder. Joint pain and muscle aches are among the recognized adverse reactions. In rare cases, methimazole can trigger what is called antithyroid arthritis syndrome, which involves severe pain in multiple joints and can make even basic movement difficult. One case report described a patient who developed debilitating pain in her hands, wrists, knees, and ankles within about three weeks of starting methimazole.¹⁰ In a pediatric study, several children developed diffuse joint pain as well.¹¹

These reactions are not common, but if you are experiencing unexplained joint pain or muscle soreness that limits your ability to be physically active, it is worth discussing with your doctor. It may be the drug rather than the disease, and switching to a different antithyroid medication or adjusting the dose could help. Fatigue is another factor: as the body transitions from a hyperthyroid state to a normal one, many people feel sluggish and low-energy for weeks or months, which makes maintaining an exercise routine genuinely difficult. This is usually temporary, but it is real and worth planning around rather than powering through.

The Overcorrection Risk

One scenario that makes weight loss especially difficult is when methimazole overshoots and pushes you into hypothyroidism, the opposite problem. If your dose is too high or not adjusted often enough, your thyroid hormone levels can drop below normal, which slows your metabolism even further and makes weight gain accelerate. The data on radioactive iodine treatment makes this pattern clear: patients who became hypothyroid after that treatment gained the most weight. The same principle applies to methimazole if the dose is not carefully managed.

Regular blood work to monitor thyroid hormone levels is critical during methimazole treatment, especially in the first year. If your levels are running low, a dose reduction can prevent the metabolic slowdown that comes with hypothyroidism. Patients who stay in the normal thyroid range throughout treatment tend to have more manageable weight trajectories than those who swing between overactive and underactive states. If you feel like your weight is climbing faster than expected or you are developing symptoms of hypothyroidism, such as extreme fatigue, constipation, feeling cold all the time, or dry skin, getting your levels checked sooner rather than later is worth it.

Weight Gain in Children and Adolescents

The weight gain pattern is not limited to adults. Children treated for Graves’ disease also gain significant amounts of weight, and the effects can be particularly persistent. A study of pediatric patients found that treated children gained substantial weight over the first six months, pushing their BMI significantly above where it started. About 25 percent of these children maintained elevated BMI scores beyond the initial treatment period, suggesting the gain was not purely temporary.¹²

For parents of children on methimazole, this is important context. A child who gains weight during treatment is experiencing an expected physiological response, not necessarily overeating or being inactive. Focusing on balanced nutrition and regular activity rather than calorie restriction is generally the recommended approach in this age group, where growth and development take priority over scale numbers.

Realistic Expectations and Practical Strategies

Given everything the research shows, here is what a realistic weight management plan on methimazole looks like:

First three months: Accept that some weight gain is likely and largely unavoidable. Focus on not dramatically overshooting by being mindful of portions, but do not severely restrict calories. Your body is rebuilding.
Three to six months: Weight gain typically slows or plateaus as your metabolic rate stabilizes. This is a reasonable time to start being more deliberate about calorie balance and physical activity.
Six months and beyond: Once thyroid levels are consistently normal, traditional weight loss strategies become more effective. Your metabolism has settled, and calorie deficits will produce results more predictably.

Strength training deserves particular emphasis. Because hyperthyroidism breaks down muscle, and because muscle tissue burns more calories at rest than fat tissue does, rebuilding that muscle is one of the most effective long-term strategies for weight management after treatment.⁹ It will not produce dramatic weight loss on the scale in the short term, but it shifts body composition in a favorable direction.

Cardiovascular exercise helps too, of course, but the intensity should match where you are in treatment. Early on, when your heart rate may still be elevated and your body is adjusting, moderate-intensity activity like walking or swimming is safer and more sustainable than aggressive high-intensity workouts. As thyroid levels normalize and your energy improves, you can ramp up gradually.

Why “Just Eat Less” Is an Incomplete Answer

The common advice to simply cut calories misses the complexity of what methimazole does to your body. You are not just a person trying to lose weight. You are a person whose metabolic rate dropped by 40 percent or more over the span of a few months while your appetite-regulating systems lagged behind. The body composition research shows that your body is simultaneously trying to add fat and rebuild muscle, two processes that pull in different directions from a weight management standpoint. And the evidence on disease severity suggests that the patients who need to lose weight most urgently, those who were most severely hyperthyroid, are precisely the ones whose bodies are most primed to overshoot their pre-illness weight.

None of this means weight loss is impossible on methimazole. It means the timing matters, the approach matters, and patience is not optional. People do lose weight successfully after their thyroid levels have stabilized, especially when they combine moderate calorie awareness with strength training and stay on top of their thyroid blood work to avoid overcorrection into hypothyroidism. The patients who struggle most are the ones who either try to diet aggressively during the first few months of treatment, when their body is fighting them hardest, or who assume the weight gain is inevitable and permanent and stop trying altogether. The middle path, where you accept the early gain as part of recovery and shift to active management once your metabolism stabilizes, tends to produce the best long-term outcomes.